— Know what they know.
Not Investment Advice

ENGN NASDAQ

enGene Holdings Inc.
1W: -7.2% 1M: -21.3% 3M: -13.4% YTD: -82.5% 1Y: -81.3%
$1.55
-0.03 (-1.90%)
 
Weekly Expected Move ±8.1%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $103.9M mcap · 25M float · 3.40% daily turnover · Short 38% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 24.3% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.14 (down 91%), enGene Holdings Inc. would be worth roughly what it owes.
Total debt $33.3M against a stock market value of $103.9M.
Distance to default 0.40 (Merton model): prices to 2026-10-27, balance sheet 2026-07-31, debt counted $15.0M (short-term plus half of long-term), stock volatility 182.8%; Altman Z'' 1.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$123M -97.7% ▼
Net Income
-$117M -112.7% ▼
EPS (Diluted)
$-2.29 -56.8% ▼
EBITDA
-$114M -118.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$175K$323K$0
Gross Profit$0$0-$175K-$323K$0
Gross Margin—————
R&D Expenses$12M$15M$16M$38M$94M
SG&A Expenses$3M$3M$9M$24M$29M
Operating Expenses$16M$19M$26M$62M$123M
Operating Income-$16M-$2M-$26M$62M-$123M
Operating Margin—————
Interest Expense$5M$1M$5M$3M$3M
Income Before Tax-$23M$31K-$100M$55M-$117M
Tax Expense$5M$0$17K-$19K$0
Net Income-$23M$31K-$100M-$55M-$117M
Net Margin—————
EPS (Diluted)$-0.01$0.00$-4.24$-1.46$-2.29
EBITDA$47K$269K-$95M-$52M-$114M
Shares Outstanding16M16M24M45M51M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms